Neurelis, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Neurelis, Inc.
Quantité totale PI 57
Rang # Quantité totale PI 24 483
Note d'activité PI 2,5/5.0    41
Rang # Activité PI 18 077
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

17 20
3 5
7 0
5
 
Dernier brevet 2025 - Intranasal olanzapine formulatio...
Premier brevet 2008 - Nasal administration of benzodia...
Dernière marque 2024 - N
Première marque 2008 - NEURELIS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Administration of benzodiazepine compositions. The invention relates to pharmaceutical compositi...
Invention Treatment of cavernous angiomas with a 4-substituted piperidine derivative. Disclosed are methods...
Invention Treatment of cavernous angiomas with a 4-substituted piperidine derivative. Disclosed are method...
Invention Oral film for rapid active delivery. The present invention discloses a method for treating neurol...
Invention Intranasal olanzapine formulations and methods of their use. Compositions for intranasal delivery...
2024 Invention Intranasal olanzapine formulations and methods of their use. Compositions for intranasal deliver...
Invention Administration of benzodiazepine compositions. The invention relates to pharmaceutical compositio...
P/S Pharmaceutical preparations for the treatment of central nervous system disorders, namely, brain,...
Invention Methods and compositions for rapid delivery of anti-seizure therapeutics. Compositions for intra...
2023 Invention Polymorphs of substituted isoquinoline-based rho kinase inhibitors. The present disclosure relate...
Invention Polymorphs of substituted isoquinoline-based rho kinase inhibitors. The present disclosure relat...
2022 Invention Methods and compositions for treating seizure disorders in pediatric patients. Compositions for ...
Invention Methods and compositions for treating seizure disorders in pediatric patients. Compositions for i...
Invention Methods and compositions for rapid delivery of anti-seizure therapeutics. Compositions for intran...
2021 P/S Providing business information related to pharmaceutical products; business management services i...
P/S Pharmaceutical services, namely, proving business information related to pharmaceutical products;...
P/S Pharmaceutical preparations for the treatment of nervous system disorders and epileptic seizures ...
2020 P/S pharmaceutical services, namely, proving business information related to pharmaceutical products;...
P/S Educational services and support related to pharmaceutical products, namely, providing trainings ...
2019 P/S Educational services and support related to pharmaceutical products, namely providing trainings a...
2018 P/S Pharmaceutical preparations for the treatment of nervous system disorders; pharmaceutical prepara...
P/S NASAL SPRAY PREPARATIONS
P/S Pharmaceutical preparations for the treatment of the central nervous system, namely, central nerv...
2015 P/S pharmaceutical preparations for the treatment of nervous system disorders; pharmaceutical prepara...
2014 P/S Pharmaceutical preparations for the treatment of nervous system disorders, namely, epilepsy and s...
2008 Invention Multimodal particulate formulations. Multimodal particulate formulations of medicaments and metho...
Invention Nasal administration of benzodiazepines. Particulate formulations of benzodiazepines, such as di...